Alterity Therapeutics Quote - ATH | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Australia
ASX
Alterity Therapeutics Ltd (ATH) Share Price

Alterity Therapeutics Ltd (ATH)

0.003

0.00

(0.00%)

Closed November 21 11:00PM

Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

0.003

Bid

0.003

Ask

0.004

Volume

16,020,097

0.003 Day's Range 0.003

0.002 52 Week Range 0.0085

Market Cap

Previous Close

0.003

Open

0.003

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

5,107,792

Shares Outstanding

2,416,418,418

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-0.01

Revenue

4.02M

Net Profit

-19.12M

Sector

Biological Pds,ex Diagnstics

Industry

Health Care Diversified

Website

www.alteritytherapeutics.com

Headquarters

Melbourne, Victoria, Aus

Founded

1997

Alterity Therapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker ATH. The last closing price for Alterity Therapeutics was AUD0. Over the last year, Alterity Therapeutics shares have traded in a share price range of AUD 0.002 to AUD 0.0085.

Alterity Therapeutics currently has 2,416,418,418 shares outstanding. The market capitalization of Alterity Therapeutics is AUD7.25 million. Alterity Therapeutics has a price to earnings ratio (PE ratio) of 0.00.

ADRs End Higher, Shell and Eisai Trade Actively

By Kathryn Hardison International stocks trading in New York closed higher on Friday. The S&P/BNY Mellon index of American depositary receipts increased 2.2% to 148.13. The European index...

Alterity Therapeutics Shares Reverse Course, Hit 52-Week Low

By Chris Wack Alterity Therapeutics Ltd. shares reversed course Tuesday, dropping 13% to 49 cents, after the company said it received approval for its investigational new drug application by the...

Alterity Therapeutics Gets FDA Approval for IND Application for ATH434

By Chris Wack Alterity Therapeutics Ltd. said it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application to allow evaluation of ATH434 in...

Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that it has successfully completed its Phase 1 study of PBT434, a novel, orally bioavailable...

Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is today releasing interim clinical data of its Phase 1 clinical trial program for its investigative drug...

Alterity Therapeutics Presents at the American Academy of Neurology Annual Meeting

Alterity Therapeutics Limited, (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) will present clinical data from its lead drug candidate PBT434 at the American Academy of Neurology...

Anthem Introduces Health and Wellness Web Site for Baby Boomers and Seniors

Anthem Introduces Health and Wellness Web Site for Baby Boomers and Seniors INDIANAPOLIS, Oct. 5 /PRNewswire/ -- Baby boomers and seniors can now access online information and tools tailored...

Anthem Annual Report Wins Gold in International Competition

Anthem Annual Report Wins Gold in International Competition INDIANAPOLIS, Sept. 21 /PRNewswire/ -- Anthem Inc.'s 2003 summary annual report has won a gold award at the 18th Annual International...

Second Diversity Leadership Academy Class Named

Second Diversity Leadership Academy Class Named INDIANAPOLIS, Aug. 26 /PRNewswire/ -- A diverse group of 58 community leaders have been selected to participate in this year's Diversity...

Anthem Recognized As One of the Top 100 Agile Companies By CIO Magazine

Anthem Recognized As One of the Top 100 Agile Companies By CIO Magazine INDIANAPOLIS, Aug. 19 /PRNewswire/ -- Anthem, Inc. has been recognized by CIO magazine as a recipient of the "2004 CIO 100...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.003	0.004	0.0025	3175648	0.003	DE
4	0	0	0.003	0.004	0.002	3772803	0.00289759	DE
12	-0.001	-25	0.004	0.004	0.002	5107792	0.00315891	DE
26	-0.002	-40	0.005	0.007	0.002	8076490	0.0042789	DE
52	-0.003	-50	0.006	0.0085	0.002	11295380	0.00486907	DE
156	-0.023	-88.4615384615	0.026	0.028	0.002	5317788	0.00774254	DE
260	-0.022	-88	0.025	0.41	0.002	7020562	0.02772341	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HIQOHitIQ Limited	AUD 0.022 (633.33%)	25k
ARDOArgent Minerals Ltd	AUD 0.003 (200.00%)	18.41M
IFGInFocus Group Holdings Ltd	AUD 0.038 (153.33%)	61.11M
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	5M
FNRFar Northern Resources Ltd	AUD 0.18 (71.43%)	142.69k
OECROrbital Corporation Limited	AUD 0.001 (-98.48%)	9
ADXOADX Energy Limited	AUD 0.011 (-63.33%)	875k
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
CRIOCritica Ltd	AUD 0.001 (-50.00%)	5M
AGEOCAlligator Energy Limited	AUD 0.01 (-28.57%)	36k
SYASayona Mining Limited	AUD 0.034 (-10.53%)	96.47M
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
88E88 Energy Limited	AUD 0.002 (33.33%)	79.47M
PENPeninsula Energy Ltd	AUD 0.0545 (-3.54%)	72.33M
LPDLepidico Ltd	AUD 0.002 (0.00%)	65.86M

Golden Cross

Golden Cross 53 seconds ago

$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]

XenaLives

XenaLives 2 minutes ago

LOL!!! DFCO is a typical BONAR pump and dump.

No fundamentals at all here.....

Methinks

Methinks 2 minutes ago

https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/
Found this, and thanks, Bull_Dolphin. I look forward to hearing more about the DAAS partnership.

aniyahsbednar

aniyahsbednar 2 minutes ago

Official Website... https://cutt.ly/BeKWwPJc

Vital Grow XL Gummies are formulated to enhance male performance, vitality, and overall wellness. Designed with convenience and natural ingredients in mind, these gummies aim to provide benefits like improved stamina, testosterone support,

Golden Cross

Golden Cross 2 minutes ago

$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]

Methinks

Methinks 6 minutes ago

https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/

"Direct Integration: WidePoint’s MobileAnchor™ generates a digital credential directly on the device, can leverage device-specific security features, such as hardware-base

diggitydoodle

diggitydoodle 10 minutes ago

A lot of giving opinions, predicting, hoping & wishing what this tickers great CEO will do. Based on reading into things without those things specifically being written in any of the reports coming out.
This great CEO can't put out timely fins. And, doesn't give updates, even of the most gen

TheFinalCD

TheFinalCD 11 minutes ago

RMSG 7
CRAZY SWINGS FROM
55- TO 2.65 TO 10.70

RMSG
https://finance.yahoo.com/news/real-messenger-nova-vision-acquisition-210800321.html

aniyahsbednar

aniyahsbednar 12 minutes ago

Official Website... https://cutt.ly/keKQ376J

MaxBoost Plus is a premium male enhancement supplement designed to help men improve stamina, vitality, and overall confidence. Using a powerful blend of natural ingredients, it supports testosterone levels, blood flow, and energy, empowerin

TrendTrade2016

TrendTrade2016 13 minutes ago

BDPT FIRST TRIP REVERSE SPLIT TO HIT...GET READY CLOWNS...THIS IS THE BEGINNING TO THEBIGGEST OTC RS CAMPAIGN IN A DECADE

Truth_is_a_tool

Truth_is_a_tool 16 minutes ago

I feel a disturbance in the force too lol and I’m going to go ahead and agree. I feel we will have a PR in less than 3 hours.

Truth_is_a_tool

Truth_is_a_tool 18 minutes ago

Hi M4N , my concern was that it was in the latest prospectus that just came out but you and Mojo are probably right that it’s just a copy and paste. Either way im not really concerned as it doesn’t change my view that this company will have a breakout soon enough , whether it’s this year or the next

Bull_Dolphin

Bull_Dolphin 20 minutes ago

Yay!!!!

https://www.breitbart.com/entertainment/2024/11/20/ellen-degeneres-leaves-united-states-flees-to-england-over-trump-election/

Minddoc7

Minddoc7 21 minutes ago

Coinbase CEO Brian Armstrong Perfect For Crypto Czar Role - Charles Hoskinson

"Cardano founder Charles Hoskinson has thrown his weight behind Coinbase CEO Brian Armstrong as the best choice for a potential “crypto czar” position in the Trump administration.

The informal

Seminole Red

Seminole Red 22 minutes ago

cowtown jay

cowtown jay 24 minutes ago

How much longer can it be before we start to see detailed stock quotes on this site (advfn) again? So many pieces of the puzzle are starting to be displayed, they have got to be near the point where they are snapped together. We've got to be generating revenue by now.

https://www.ad

aniyahsbednar

aniyahsbednar 27 minutes ago

Official Website... https://cutt.ly/qeKQMuOM

VitalRize Male Enhancement is a cutting-edge supplement designed to help men regain their stamina, boost testosterone levels, and improve overall confidence. With a blend of natural and clinically tested ingredients, VitalRize offers a holi

aniyahsbednar

aniyahsbednar 41 minutes ago

Official Website... https://cutt.ly/2eKQSgxD

Green Regimen Energy and Focus is a dietary supplement designed to enhance energy levels and improve mental focus naturally. Crafted with clean, plant-based ingredients, it is often marketed as a solution for those looking to maintain peak

meshcan

meshcan 41 minutes ago

Great investment in R&D. Nasrat has said they will only develop the big drugs who have $1B+ annual sale. So we should see our pipeline get better and better.

MoneyMaker111

MoneyMaker111 42 minutes ago

GME to close at or above $30 todayyy?

$GME ( Hyper Bullish / Apish )
#GME ( Hyper Bullish / Apish )

Alterity Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions